NYSE - Nasdaq Real Time Price USD

Perrigo Company plc (PRGO)

31.93

+0.66

(+2.11%)

As of 1:10 PM EDT. Market Open.

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million

Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that pharmaceutical company Esteve Healthcare, S.L. ("ESTEVE") has signed a binding offer to acquire Perrigo's HRA Pharma Rare Diseases business for a total consideration of up to €275 million, consisting of an upfront cash payment of €190 million and up to €85 million in potential earnout payments based on the Rare Diseases business achieving certain sales milestones.

PR Newswire yesterday

PRGO
+2.11%
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT).

PR Newswire 3 days ago

PRGO
+2.11%
Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]

Insider Monkey 11 days ago

PRGO
+2.11%
The WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control

Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.

Fortune 15 days ago

PRGO
+2.11%
Opill and WNBA Team Up for Groundbreaking Partnership

Today, Perrigo Company plc, a leading provider of Consumer Self-Care Products, announced that Opill® — the first-ever daily birth control pill available without a prescription in the U.S. — and the Women's National Basketball Association (WNBA) have entered a multi-year partnership that focuses on building confidence, strength and health equity, all of which closely align with both organizations' core priorities.

PR Newswire 17 days ago

PRGO
+2.11%
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors

CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp, will add Perrigo's birth control pill to its preventive services oral contraceptives list and make it available at no cost for many plan sponsors, according to a pharmacy update on March 28. The U.S. FDA in July approved over-the-counter use of Perrigo's drug Opill, making it the first oral contraceptive in the country which can be purchased without prescription.

Reuters 21 days ago

PRGO
+2.11%
CVS
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 29 days ago

PRGO
+2.11%
BIO-B
Prepare for Takeoff With Perrigo

A closer look at one of the leaders in the global over-the-counter pharmaceuticals market

GuruFocus.com last month

PRGO
+2.11%
Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript

Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript February 27, 2024 Perrigo Company plc beats earnings expectations. Reported EPS is $0.86, expectations were $0.83. PRGO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the […]

Insider Monkey last month

PRGO
+2.11%
First over-the-counter birth control pill in US begins shipping to stores

The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin. Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription.

Associated Press Finance last month

PRGO
+2.11%
Over-the-Counter Birth Control Pill to Be Available Within Weeks on Retail Shelves

Birth control pills without a prescription will be available on retail shelves for the first time in the U.S. this month. The over-the-counter contraceptive pills—branded as Opill and made by health-product company Perrigo —will soon become the most effective birth-control method available without a doctor’s visit. The drug represents a milestone that reproductive activists have pursued for decades and comes as women’s fertility is at the center of a national conversation on abortion and in vitro fertilization.

The Wall Street Journal last month

PRGO
+2.11%
Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that Opill® has shipped to major retailers and pharmacies and will be available on shelves nationwide and online later this month. Approved by the U.S. Food and Drug Administration (FDA) for OTC use for all ages in July 2023, Opill® is the first-ever daily birth control pill available without a prescription in the U.S.

PR Newswire last month

PRGO
+2.11%
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices

Underdogs stocks carry almost universal appeal. It’s one thing to go with the rest of the crowd. It’s quite another to take your time to find some diamonds in the rough that could yield considerable returns. Basically, these hidden gems represent the universal desire to pioneer a particular accomplishment. For example, we all remember who first stepped foot on the moon. We don’t really discuss who was the last person to do it, as monumental of a triumph that it is. Now, that’s not to say that yo

InvestorPlace last month

EXAS

PRGO
+2.11%
PAASF
Here's Why We're Wary Of Buying Perrigo's (NYSE:PRGO) For Its Upcoming Dividend

Perrigo Company plc ( NYSE:PRGO ) stock is about to trade ex-dividend in four days. The ex-dividend date occurs one day...

Simply Wall St. last month

PRGO
+2.11%
Perrigo (NYSE:PRGO) Is Paying Out A Larger Dividend Than Last Year

Perrigo Company plc ( NYSE:PRGO ) will increase its dividend on the 26th of March to $0.276, which is 1.1% higher than...

Simply Wall St. last month

PRGO
+2.11%
Perrigo to Attend UBS Global Consumer and Retail Conference

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the UBS Global Consumer and Retail Conference in New York City on Wednesday, March 13th at 4:00 PM EST.

PR Newswire last month

PRGO
+2.11%
Perrigo (PRGO) Q4 Earnings Top, Sales Lag Estimates, Misses View

Perrigo (PRGO) reports mixed fourth-quarter 2023 results. Management issues fresh financial outlook for 2024, which were below our expectations. Stock price drops 10% after this announcement.

Zacks last month

PRGO
+2.11%
Compared to Estimates, Perrigo (PRGO) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks last month

PRGO
+2.11%
Perrigo Co PLC (PRGO) Posts Record Net Sales in Q4 and FY 2023, Launches Efficiency Program

Robust Financial Performance and Strategic Initiatives Mark Perrigo's Year-End Results

GuruFocus.com last month

PRGO
+2.11%
Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program

Fourth Quarter 2023 Highlights:

PR Newswire last month

PRGO
+2.11%

Performance Overview

Return	PRGO	S&P 500
YTD	+0.21%	+7.17%
1-Year	-8.62%	+25.55%
3-Year	-16.54%	+22.29%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Perrigo Company plc (PRGO)

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million

Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024

Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1

The WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control

Opill and WNBA Team Up for Groundbreaking Partnership

CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors

Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?

Prepare for Takeoff With Perrigo

Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript

First over-the-counter birth control pill in US begins shipping to stores

Over-the-Counter Birth Control Pill to Be Available Within Weeks on Retail Shelves

Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States

Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices

Here's Why We're Wary Of Buying Perrigo's (NYSE:PRGO) For Its Upcoming Dividend

Perrigo (NYSE:PRGO) Is Paying Out A Larger Dividend Than Last Year

Perrigo to Attend UBS Global Consumer and Retail Conference

Perrigo (PRGO) Q4 Earnings Top, Sales Lag Estimates, Misses View

Compared to Estimates, Perrigo (PRGO) Q4 Earnings: A Look at Key Metrics

Perrigo Co PLC (PRGO) Posts Record Net Sales in Q4 and FY 2023, Launches Efficiency Program

Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program

Performance Overview